Human platelets effectively kill K-562 cells, a chronic myelogenic leukemia cell line, in vitro.

Synergistic effect of HMGB1 knockdown and cordycepin in the K562 human chronic myeloid leukemia cell line.

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.

In vitro anti-telomerase activity of novel lycopene-loaded nanospheres in the human leukemia cell line K562.

Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate in human leukemia cell line, K562.

Differential gene expression analysis in k562 human leukemia cell line treated with benzene.

Thrombin-induced calcium oscillation in human platelets and MEG-01, a megakaryoblastic leukemia cell line.

miR-155 effectively induces apoptosis in K562 Philadelphia positive cell line through upregulation of p27kip1.

Human granulocyte antigens detected on leukemia cells and a chronic myelogenous cell line.

Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.

Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells.

Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells.

Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis.

Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism.

Analysis of the erythroid differentiation effect of flavonoid apigenin on K562 human chronic leukemia cells.

Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.

Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line.

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells.

Cloning and expression of the functional human anti-vascular endothelial growth factor (VEGF) using the pcDNA3.1 vector and the human chronic myelogenous leukemia cell line K562.

mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line.

Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.

Rubus parvifolius L. inhibited the growth of leukemia K562 cells in vitro and in vivo.

Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.

Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells.

$Induction of apoptosis by Cordyceps militaris fraction in human chronic myeloid leukemia K562 cells involved with mitochondrial dysfunction.$
Induction of apoptosis by Cordyceps militaris fraction in human chronic myeloid leukemia K562 cells involved with mitochondrial dysfunction.

Suggest Documents

Synergistic effect of HMGB1 knockdown and cordycepin in the K562 human chronic myeloid leukemia cell line.

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.

In vitro anti-telomerase activity of novel lycopene-loaded nanospheres in the human leukemia cell line K562.

Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate in human leukemia cell line, K562.

Differential gene expression analysis in k562 human leukemia cell line treated with benzene.

Thrombin-induced calcium oscillation in human platelets and MEG-01, a megakaryoblastic leukemia cell line.

miR-155 effectively induces apoptosis in K562 Philadelphia positive cell line through upregulation of p27kip1.

Human granulocyte antigens detected on leukemia cells and a chronic myelogenous cell line.

Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.

Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells.

Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells.

Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis.

Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism.

Analysis of the erythroid differentiation effect of flavonoid apigenin on K562 human chronic leukemia cells.

Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.

Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line.

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells.

Cloning and expression of the functional human anti-vascular endothelial growth factor (VEGF) using the pcDNA3.1 vector and the human chronic myelogenous leukemia cell line K562.

mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line.

Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.

Rubus parvifolius L. inhibited the growth of leukemia K562 cells in vitro and in vivo.

Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.

Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells.

Induction of apoptosis by Cordyceps militaris fraction in human chronic myeloid leukemia K562 cells involved with mitochondrial dysfunction.

Human platelets effectively kill K-562 cells, a chronic myelogenic leukemia cell line, in vitro.

Recommend Documents

Follow Us